Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01575288 · ClinicalTrials.gov registry record · NA
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01575288 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 110 participants.
The verdict
NCT01575288, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The proposed study will assess the ability of a naturally occurring sugar to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.
Interventions
- DRUG Placebo
- DRUG High-dose trehalose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01575288
The ClinicalTrials.gov registry entry for NCT01575288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01575288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01575288 about?
NCT01575288 is a clinical study titled "Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults". The proposed study will assess the ability of a naturally occurring sugar to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for tr...
What is the current status of trial NCT01575288?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2012-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01575288?
The interventions under investigation include: Placebo (DRUG), High-dose trehalose (DRUG).
Who is sponsoring clinical trial NCT01575288?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.